Body Mass Index, Fasting Blood Sugar Above Normal, Lipid Profile
Conditions
Keywords
Symbiotic Beverages, Lipid Profile, Body Mass Index
Brief summary
The goal of this clinical trial is to evaluate whether the synbiotic beverage Daygurt can improve lipid profiles, blood sugar levels, blood pressure, and body weight in individuals diagnosed with dyslipidemia. The main questions it aims to answer are: Does Daygurt significantly reduce total cholesterol and LDL levels compared to nutrition counseling alone? Does Daygurt increase HDL levels and reduce triglycerides more effectively than nutrition counseling? Does Daygurt lead to greater improvements in fasting blood sugar, blood pressure, and body weight compared to nutrition counseling? The intervention group (receiving Daygurt plus nutrition counseling) will be compared to the comparison group (receiving nutrition counseling without Daygurt) to see if Daygurt provides additional benefits beyond standard dietary advice. Participants will be divided into 2 groups: Intervention group: Consume Daygurt daily for 8 weeks. Comparison group: Receive nutrition counseling sessions focused on managing dyslipidemia but will not consume Daygurt. Both groups will undergo health parameter measurements before and after the intervention, including: Total cholesterol, LDL, HDL, and triglyceride levels. Fasting blood sugar. Blood pressure. Body mass index (BMI).
Interventions
DIETARY_SUPPLEMENTSYMBIONIC
Provision of 100 ml symbiotic beverages daygurt per day for 6 weeks, plus standard dietary advice for dyslipidemia
BEHAVIORALDietary advice
Participants get standard dietary advice for dyslipidemia
Sponsors
Politeknik Kesehatan Kemenkes Padang
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE
Intervention model description
This trial is a controlled clinical studies conducted to evaluate the effectiveness of the symbiotic drink for improving lipid profiles, blood sugar and nutritional status in participants with hypercholesterolemia or overweight under study and to determine the common short-term side effects and risks.
Eligibility
Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No
Inclusion criteria
* Cholesterol total above 200 mg/dl, or LDL Cholesterol above 100, or BMI above 25 kg/m2 * Agree to study protocols
Exclusion criteria
* Has Allergic to dairy product * Having any drug lowering cholesterol
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Lipid profile | 6 weeks (before and after intervention) | Fasting Total blood cholesterol, LDL cholesterol, HDL cholesterol and triglyceride level measured before and after intervention phase |
Countries
Indonesia
Outcome results
None listed